Awardee OrganizationUT SOUTHWESTERN MEDICAL CENTER
Description
Abstract Text
DEVELOPMENTAL FUNDS
Project Summary/Abstract
Developmental funds are used to support new investigator projects; pilot projects that
allow Center scientists and clinical investigators to pursue innovative ideas in high-priority
research areas; and new technologies that will advance cancer research. CCSG funds are
combined with institutional and philanthropic resources to provide the funding for up to
eight new investigator awards at $40,000 each, $200,000 for pilot projects, and $100,000
for new technology development. The Senior Leaders Council evaluates and ranks new
investigator projects for funding. Advocacy for pilot projects and shared resource
technology enhancements come from senior and program leaders as well as shared
resource directors and are evaluated for support by the Senior Leadership Council.
Over the past four years, 31 new investigator awards were made to faculty representing 14
departments. To date, one-half have secured a combined $16.5 million in peer-reviewed
funding. CCSG funds have also been used to leverage institutional investments to
enhance the services provided by the Cancer Center's High-Throughput Screening,
Bioinformatics, and Tissue Management Shared Resources. During the past grant period,
additional institutional resources supported pilot project awards to catalyze research
thrusts in lung cancer, glioma, pancreas cancer, neurofibromatosis, kidney cancer, and
hepatocellular cancer, and to launch investigator-initiated clinical trials designed to bring
Simmons Cancer Center discovery to patients.
In this renewal application, developmental funds amounting to $100,000, or 10% of the
annual direct cost of the proposed Cancer Center Support Grant budget, are requested.
These funds will be combined with institutional and philanthropic support to continue a high-
impact new investigator award program, to enhance shared resources, and to fund pilot
projects in high-priority areas identified by Cancer Center leadership. Because a budget cap
limits the overall funds available, CCSG support for recruitment is not requested.
Substantial institutional funds are available to continue targeted recruitment, and these
recruitment priorities are discussed.
Relevance
Developmental funds are used to further the Cancer Center's strategic initiatives. CCSG funds
are used to leverage institutional and philanthropic support and provide a mechanism for
senior and program leaders to engage faculty in cancer research and in development of
targeted research areas.
Public Health Relevance Statement
Data not available.
NIH Spending Category
Cancer Rare Diseases
Project Terms
Advanced Malignant NeoplasmAdvocacyAreaAwardBioinformaticsBudgetsCancer CenterCancer Center Support GrantClinical InvestigatorClinical Trials DesignDevelopmentDirect CostsEnhancement TechnologyEvaluationFacultyFundingGliomaGrantInstitutional support resourcesInvestmentsLeadershipMalignant neoplasm of lungMalignant neoplasm of pancreasMedical centerNeurofibromatosesPatientsPeer ReviewPhilanthropic FundPilot ProjectsPrimary carcinoma of the liver cellsProcessRenal carcinomaResearchResearch PersonnelResearch PriorityResource SharingResourcesScientistSecureSeedsServicesTargeted ResearchTechnologyTissuesanticancer researchhigh throughput screeninginnovationnew technologyprogramsrecruittechnology development
No Sub Projects information available for 5P30CA142543-10 6350
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30CA142543-10 6350
Patents
No Patents information available for 5P30CA142543-10 6350
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30CA142543-10 6350
Clinical Studies
No Clinical Studies information available for 5P30CA142543-10 6350
News and More
Related News Releases
No news release information available for 5P30CA142543-10 6350
History
No Historical information available for 5P30CA142543-10 6350
Similar Projects
No Similar Projects information available for 5P30CA142543-10 6350